CRIS Current Research Information System

TAROZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.923
AS - Asia 6.384
EU - Europa 5.443
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 413
SA - Sud America 364
OC - Oceania 18
Totale 20.043
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.747
IT - Italia 1.793
CN - Cina 1.740
SG - Singapore 1.614
VN - Vietnam 1.526
GB - Regno Unito 930
DE - Germania 573
SE - Svezia 539
HK - Hong Kong 398
IN - India 301
FR - Francia 271
BR - Brasile 265
UA - Ucraina 243
RU - Federazione Russa 209
BD - Bangladesh 205
NL - Olanda 192
KR - Corea 171
IE - Irlanda 168
JP - Giappone 113
TG - Togo 104
FI - Finlandia 99
CI - Costa d'Avorio 90
CA - Canada 89
ZA - Sudafrica 84
BG - Bulgaria 73
SC - Seychelles 69
EE - Estonia 61
AR - Argentina 47
TW - Taiwan 47
ES - Italia 44
ID - Indonesia 44
MX - Messico 40
BE - Belgio 39
PH - Filippine 38
CH - Svizzera 36
NG - Nigeria 32
TR - Turchia 30
GR - Grecia 28
HR - Croazia 27
AT - Austria 26
TH - Thailandia 22
IQ - Iraq 21
PL - Polonia 21
JO - Giordania 20
PK - Pakistan 19
IR - Iran 15
AU - Australia 14
CZ - Repubblica Ceca 14
JM - Giamaica 14
PT - Portogallo 13
CL - Cile 11
MY - Malesia 11
EC - Ecuador 10
EG - Egitto 10
RO - Romania 10
UZ - Uzbekistan 9
VE - Venezuela 9
CR - Costa Rica 8
DK - Danimarca 8
LB - Libano 8
HN - Honduras 7
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CO - Colombia 5
DZ - Algeria 5
KE - Kenya 5
KZ - Kazakistan 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
MA - Marocco 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
SM - San Marino 4
AL - Albania 3
SN - Senegal 3
BY - Bielorussia 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BS - Bahamas 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EU - Europa 1
GH - Ghana 1
Totale 19.532
Salva come PNG Salva come JPEG
Città #
Singapore 1.096
Southend 775
Ashburn 649
Bologna 531
Fairfield 489
Santa Clara 418
Chandler 413
Hefei 383
Hong Kong 374
San Jose 366
Ho Chi Minh City 347
Houston 309
Hanoi 286
Wilmington 255
Woodbridge 252
Seattle 229
Ann Arbor 212
Council Bluffs 211
Beijing 210
Dong Ket 198
Princeton 187
Cambridge 186
Jacksonville 168
Dublin 162
Seoul 143
Boardman 141
Los Angeles 117
New York 115
Lomé 104
Lauterbourg 97
Milan 91
Abidjan 90
Nanjing 84
Tokyo 83
Dallas 75
Helsinki 75
Westminster 73
Sofia 72
Buffalo 70
Berlin 66
Padova 66
Redmond 64
Turin 59
Shenyang 56
Rome 50
San Diego 50
Da Nang 47
Rimini 47
Bengaluru 41
Guangzhou 41
Jinan 40
Munich 39
Saint Petersburg 39
Bremen 37
Haiphong 36
Brussels 33
Phoenix 33
Changsha 32
Frankfurt am Main 32
San Giorgio di Piano 32
Jakarta 31
Redondo Beach 31
Redwood City 31
São Paulo 31
Abeokuta 29
Medford 29
Cesena 28
Johannesburg 28
Chicago 25
Hebei 25
Hyderabad 25
Tianjin 25
Mülheim 24
Nuremberg 24
Shanghai 24
Bern 23
Des Moines 23
Hải Dương 23
Nanchang 23
Toronto 23
Biên Hòa 22
Hangzhou 22
Zhengzhou 22
Montreal 21
Naples 21
Amman 20
Forlì 20
Modena 20
Mahé 19
Philadelphia 19
Amsterdam 18
Dearborn 18
Portogruaro 18
Falls Church 17
Jiaxing 17
Orem 17
The Dalles 17
Verona 17
Bari 16
Boydton 16
Totale 11.978
Salva come PNG Salva come JPEG
Nome #
Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease 375
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 345
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 343
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 326
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 302
Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease 299
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 298
P-glycoprotein (ABCB1) and oxidative stress: Focus on Alzheimer's disease 289
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 286
Heat stress as a potential risk factor for vitamin D deficiency 262
Circulating Cell-Free DNA in Physical Activities 249
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 242
Antioxidant and Neuroprotective Effects of Fucoxanthin and Its Metabolite Fucoxanthinol: A Comparative In Vitro Study 240
Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways 227
PQM130, a novel feruloyl-donepezil hybrid compound, effectively ameliorates the cognitive impairments and pathology in a mouse model of Alzheimer's disease 221
Rational Approach to discover multipotent anti-Alzheimer drugs 220
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 219
Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases 218
Protective effects of 6-(Methylsulfinyl)hexyl isothiocyanate on Aβ1-42-induced cognitive deficit, oxidative stress, inflammation, and apoptosis in mice 218
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 216
Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson's Disease Data 215
Meta-analysis of Parkinson's disease transcriptome data using TRAM software: Whole substantia nigra tissue and single dopamine neuron differential gene expression 214
Antioxidant effectiveness of organically and non organically grown red oranges in cell culture systems 213
Neuroprotective effect of caffeic acid phenethyl ester in a mouse model of alzheimer's disease involves Nrf2/HO-1 pathway 213
The Keap1/Nrf2-ARE pathway as a pharmacological target for chalcones 211
Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed neuroprotective agents. 209
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold 208
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 208
Associazione tra un isotiocianato e levodopa per il trattamento della malattia di Parkinson 202
Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment 199
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 195
Cold-storage affects antioxidant properties of apples in Caco-2 cells. 193
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease 192
Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease 191
Esculetin as a Bifunctional Antioxidant Prevents and Counteracts the Oxidative Stress and Neuronal Death Induced by Amyloid Protein in SH-SY5Y Cells 191
Bioattività di fragole (Fragaria ananassa) da coltivazione biodinamica e convenzionale. 189
Antioxidant and Anti-Melanogenesis Effects of Teucrium chamaedrys L. Cell Suspension Extract and Its Main Phenylethanoid Glycoside in B16-F10 Cells 187
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 187
Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors 187
Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates 183
Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease. 183
Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer’s disease 182
Effetti della cianidina-3-O-beta-glucopiranoside sul danno cellulare indotto dai raggi UVA in cheratinociti in coltura. 182
Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson’s disease 181
META-ANALYSIS OF SUBSTANTIA NIGRA TRANSCRIPTOME DATA: SEARCHING FOR NEW BIOMARKERS OF PD 181
Relevance of apple consumption for protection against oxidative damage induced by hydrogen peroxide in human lymphocytes. 179
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 179
Chrysin bonded to β-d-glucose tetraacetate enhances its protective effects against the neurotoxicity induced by aluminum in Swiss mice 177
Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. 176
Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity. 176
Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases 175
Potenziale azione protettiva e antiossidante delle mele nei confronti del danno genetico indotto dal perossido di idrogeno in linfociti umani. 174
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line. 173
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease 172
Red chicory (Cichorium intybus L. cultivar) as a potential source of antioxidant anthocyanins for intestinal health 172
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 169
Design, synthesis, and biological evaluation of new thalidomide–donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation 168
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 166
Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease 165
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 163
Cyanidin 3-O-glucopyranoside protects and rescues SH-SY5Y cells against amyloid-beta peptide-induced toxicity. 161
Protective effects of chrysin against the neurotoxicity induced by aluminium: In vitro and in vivo studies 161
Lipocrine, a multipotent drug for the investigation of Alzheimer's disease 159
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate. 159
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease. 158
Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors 156
From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold 154
Protective effects of sulforaphane against oxidative stress-induced apoptosis in human neuronal cells 153
A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models 152
One-molecule-multiple-target strategy: a novel multifunctional molecule designed to block EGF-r and to exert pro-apoptotic effects 152
Neuroprotective effects of sulforaphane in an in vitro model of Parkinson’s disease 152
Effetti antiapoptotici e antiossidanti della cianidina-3-O-beta-glucopiranoside e del suo aglicone in una linea neuronale umana. 151
Neuroprotection by Drugs, Nutraceuticals and Physical Activity 150
Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. 150
Design, Synthesis and Biological Evaluation of Novel Triazole N-acylhydrazone Hybrids for Alzheimer's Disease 150
Multi-target-directed drug design strategy: quinone derivatives designed to block amyloid-beta aggregation and to exert antioxidant effects 148
Qualità e sicurezza degli alimenti da agricoltura biologica 147
Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects 147
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks 145
Discovery and evaluation of enantiopure 9H-pyrimido[4,5‐b]indoles as nanomolar GSK‐3β inhibitors with improved metabolic stability 145
Isothiocyanates as potentials alzheimer's disease-modifying drugs. 142
La cianidina 3-O-glucopiranoside protegge le cellule neuronali in coltura dalla tossicità indotta dal peptide beta-amiloide. 141
null 141
Influence of Cultivation System on Bioactive Molecules Synthesis in Strawberries: Spin-off on Antioxidant and Antiproliferative Activity 140
Urinary Markers and Chronic Effect of Physical Exercise 140
Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblatoma cell line. 137
La guanosina inibisce l'apoptosi indotta dalla proteina beta amiloide mediante upregulation dell'attività del proteasoma in una linea neuronale umana. 137
Cyanidin 3-O-glucopyranoside protects Sh-SY5Y cells against amyloid-B-peptide-induced toxicity 135
Targeting Alzheimer’s disease neurotoxicity by functionalization of the chalcone scaffold 134
Optimization of the Extraction from Spent Coffee Grounds Using the Desirability Approach 134
Sulforaphane counteracts oxidative stress induced apoptosis in human neuronal cells 131
Chalcone-based carbamates for Alzheimer's disease treatment 131
Esculetin provides neuroprotection against mutant huntingtin-induced toxicity in huntington’s disease models 130
La malattia di Parkinson: uno studio integrato tra genotipo funzionale e fenotipo patologico per lo sviluppo di nuove strategie di neuroprotezione 129
Curcumin and Heme Oxygenase: Neuroprotection and Beyond 126
null 123
Involvement of the proteasome system activation in the anti-apoptotic activity of guanine-based purines. 123
Cruciferae vegetables: a source of phytochemicals for brain health. 120
null 118
Development of new extracts of crocus sativus l. By-product from two different italian regions as new potential active ingredient in cosmetic formulations 118
Totale 18.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.496
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.817 0 64 114 154 159 136 44 166 117 248 349 266
2022/20231.964 193 245 78 255 172 152 123 118 314 45 186 83
2023/2024937 42 120 86 94 54 188 59 94 26 65 48 61
2024/20252.896 148 344 270 169 582 127 222 101 53 197 189 494
2025/20267.134 530 761 601 526 667 337 713 296 1.350 558 353 442
2026/2027420 273 147 0 0 0 0 0 0 0 0 0 0
Totale 20.043